Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
Led by Executive Chairman Michael Saylor, the company also added to its bitcoin holdings last week, bringing its total stack to 650,000 BTC....
DOT collapsed to $2.02 as technical breakdown accelerated on massive volume, exposing the psychological $2.00 level....
President Donald Trump spoke with families of National Guard members Sarah Beckstrom and Andrew Wolfe after they were shot in Washington D.C. last week....
